Definium Therapeutics, Inc. (DFTX): SCHEDULE 13G filed Nov 5, 2026

Form type

SCHEDULE 13G

Filing date

Nov 5, 2026

Accession number

0000315066-26-002739

Filer

Definium Therapeutics, Inc. (CIK 1813814)